Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-25 8:39 pm Purchase | 13G | LEAP THERAPEUTICS INC LPTX | Samsara BioCapital L.P. | 2,442,352 6.4% | 2,442,352 (New Position) | View |
| 2024-03-29 4:06 pm Purchase | 13D | NKARTA INC NKTX | Samsara BioCapital L.P. | 3,768,035 5.4% | 900,000 (+31.38%) | View |
| 2024-03-25 8:42 pm Purchase | 13G | LENZ THERAPEUTICS INC LENZ | Samsara BioCapital L.P. | 1,213,865 4.8% | 1,213,865 (New Position) | View |
| 2024-03-05 7:52 pm Purchase | 13D | VTV THERAPEUTICS INC VTVT | Samsara BioCapital L.P. | 265,620 10.4% | 265,620 (New Position) | View |
| 2024-02-14 4:19 pm Sale | 13G | RAIN ONCOLOGY INC. RAIN | Samsara BioCapital L.P. | 0 0% | -2,260,652 (Position Closed) | View |
| 2024-02-14 4:16 pm Purchase | 13G | NEUROGENE INC NGNE | Samsara BioCapital L.P. | 1,282,563 9.99% | 1,282,563 (New Position) | View |
| 2024-02-12 4:48 pm Purchase | 13D | MINERALYS THERAPEUTICS INC MLYS | Samsara BioCapital L.P. | 5,092,027 10.3% | 570,222 (+12.61%) | View |
| 2023-12-26 5:19 pm Purchase | 13D | SYROS PHARMACEUTICALS INC SYRS | Samsara BioCapital L.P. | 2,515,523 9.5% | 909,977 (+56.68%) | View |
| 2023-12-18 5:14 pm Purchase | 13G | IO BIOTECH INC IOBT | Samsara BioCapital L.P. | 3,640,015 5.5% | 3,640,015 (New Position) | View |
| 2023-11-22 4:15 pm Sale | 13D | CHINOOK THERAPEUTICS INC KDNY | Samsara BioCapital L.P. | 0 0% | -5,181,557 (Position Closed) | View |
| 2023-11-21 4:15 pm Purchase | 13G | CARGO THERAPEUTICS INC CRGX | Samsara BioCapital L.P. | 4,121,689 10.7% | 4,121,689 (New Position) | View |
| 2023-10-20 4:15 pm Purchase | 13D | SYROS PHARMACEUTICALS INC SYRS | Samsara BioCapital L.P. | 1,605,546 7.5% | 1,605,546 (New Position) | View |
| 2023-10-18 5:27 pm Purchase | 13D | SCHOLAR ROCK HLDG CORP SRRK | Samsara BioCapital L.P. | 7,878,302 11% | 2,202,226 (+38.80%) | View |
| 2023-08-25 4:15 pm Purchase | 13G | LYRA THERAPEUTICS INC LYRA | Samsara BioCapital L.P. | 2,780,261 5.6% | 2,780,261 (New Position) | View |
| 2023-02-24 4:00 pm Purchase | 13D | MINERALYS THERAPEUTICS INC MLYS | Samsara BioCapital L.P. | 4,521,805 11.1% | 4,521,805 (New Position) | View |
| 2023-02-14 5:07 pm Purchase | 13G | GRAPHITE BIO INC GRPH | Samsara BioCapital L.P. | 8,497,067 14.6% | 645,134 (+8.22%) | View |
| 2023-02-14 5:05 pm Purchase | 13D | SCHOLAR ROCK HLDG CORP SRRK | Samsara BioCapital L.P. | 5,676,076 10.8% | 5,676,076 (New Position) | View |
| 2023-02-14 5:00 pm Purchase | 13G | RAIN ONCOLOGY INC. RAIN | Samsara BioCapital L.P. | 2,260,652 9.1% | 2,260,652 (New Position) | View |
| 2023-02-14 4:56 pm Purchase | 13D | NKARTA INC NKTX | Samsara BioCapital L.P. | 2,868,035 5.9% | 833,332 (+40.96%) | View |
| 2022-06-01 4:00 pm Purchase | 13D | CHINOOK THERAPEUTICS INC KDNY | Samsara BioCapital L.P. | 5,181,557 8.4% | 5,181,557 (New Position) | View |